Why did the FDA Issue Its Highest Alert for Certain Heart Pumps? July 5, 2024 On March 21, 2024, the US Food and Drug Administration (FDA) classified the recall of Abiomed’s Impella left-sided pumps as a “Class I recall,” the agency’s “most serious type of recall.” This is a classification the FDA uses when a device imposes a risk of serious injuries or death. The FDA warned that using these […] Read More
Data Emerges as a Tool to Combat Human Trafficking July 1, 2024 An investigation by The Independent, published yesterday, shows that alleged sex trafficking at Red Roof Inn hotels has reached “epidemic levels.” According to The Independent reporters, hundreds of sex trafficking victims are filing lawsuits against the massive hotel chain and its franchisees, accusing them of turning a blind eye and profiting from human trafficking abuse. […] Read More
Supreme Court Decision in Purdue Opioids Case Heralds Grim Future for J&J Bankruptcy Protection June 27, 2024 The nation’s top court says the U.S. Bankruptcy Code is not an appropriate avenue to handle all collective action problems that come its way. The Supreme Court entered its decision (HARRINGTON, UNITED STATES TRUSTEE, REGION 2 v. PURDUE PHARMA L. P. ET AL.), saying bankruptcy courts have no business handling claims unless a company is […] Read More